Company intelligence / Profile preview

Baker Brothers Advisors

New York, New York, United Statesen.wikipedia.org ↗

Ownership: Private
Development stage: Other

Overview

Baker Brothers Advisors is a leading, highly influential hedge fund and investment management firm specializing in biotechnology and life sciences. Founded by Felix and Julian Baker in 2000, the New York-based firm manages over $9 billion as of Q1 2025, with historical AUM exceeding $20 billion at times. The fund is known for its concentrated bets on high-potential biotech companies and has generated some of the industry's largest returns through long-term holdings such as Seagen (acquired by Pfizer). Their approach involves deep scientific diligence, active board participation, and close relationships with portfolio company management teams[1][2][3][6].

Industry: Investors

Beyond the preview

Go deeper on Baker Brothers Advisors.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Baker Brothers Advisors.

Explore the full profile